Rare diseases
Investigational molecules
Locations
Study of Atezolizumab with High Dose Radiation vs. Radiation Alone for Patients with Oligometastatic Soft Tissue Sarcoma
FranceStudy of L19IL2 and L19TNF for Patients with Skin Cancer Suitable for Direct Tumor Injection
FranceStudy of Cemiplimab Alone and with RP1 for Patients with Advanced Skin Squamous Cell Carcinoma
FranceStudy on the Safety and Effects of PT-112 for Patients with Advanced Prostate Cancer
FranceStudy of TAK-280, Tocilizumab, and Siltuximab for Patients with Advanced or Metastatic Cancer
FranceStudy Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer
FranceStudy of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors
FranceStudy on Lutetium (177Lu) Vipivotide Tetraxetan for Men with Progressive Metastatic Castration-Resistant Prostate Cancer
FranceStudy on the Safety and Effectiveness of Vidutolimod and Cemiplimab for Adults with Advanced or Metastatic Cancer
FranceStudy Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments
FranceStudy of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin
FranceStudy of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
